Valuation: C&R Research Inc.

Market Cap 21.79B 15.46M 13.37M 12.49M 11.46M 21.55M 1.47B 21.89M 147M 57.52M 738M 58.06M 56.79M 2.44B P/E 2024
17.1x
P/E 2025 19.9x
Enterprise Value 19.12B 13.56M 11.73M 10.96M 10.05M 18.91M 1.29B 19.21M 129M 50.46M 647M 50.94M 49.82M 2.14B EV / Sales 2024
0.98x
EV / Sales 2025 0.75x
Free-Float
36.73%
Yield 2024
0.86%
Yield 2025 -
1 day+1.17%
1 week+11.60%
Current month+7.30%
1 month+7.85%
3 months-49.03%
6 months-56.81%
Current year-57.87%
1 week 1,752
Extreme 1752
1,989
1 month 1,671
Extreme 1671
2,015
Current year 1,667
Extreme 1667
4,870
1 year 1,667
Extreme 1667
5,890
3 years 1,667
Extreme 1667
11,975
5 years 1,667
Extreme 1667
13,400
10 years 1,667
Extreme 1667
13,400
Manager TitleAgeSince
Chief Executive Officer 74 08/12/2021
Director of Finance/CFO 49 -
President 56 -
Director TitleAgeSince
Director/Board Member 74 08/12/2021
Director/Board Member 62 28/10/2021
Director/Board Member 56 -
Date Insider Type Main position Quantity % Market Cap.
22/12/24 Sell 73,163 0.1290%
23/09/24 Buy 6,675 0.0118%
23/09/24 Buy 13,325 0.0236%
Change 5-day change 1-year change 3-year change Capi.($)
+1.17%+11.60%-63.29%-70.19% 15.14M
+0.99%+0.35%+4.91%+16.06% 48.7B
+3.71%+9.40%+486.98%+592.14% 42.05B
+2.70%+1.57%+33.39%+8.85% 38.26B
+5.60%+10.21%+16.76%+85.72% 37.5B
+2.21%+4.89%+17.24%+51.64% 31.44B
+2.23%+4.71% - - 16.47B
+0.97%+2.35%+37.75%+126.84% 16.33B
-0.11%+1.75%+8.05%+18.47% 13.98B
+0.75%+15.04%+78.59%+30.30% 12.68B
Average +2.06%+3.23%+68.93%+95.54% 25.74B
Weighted average by Cap. +2.58%+2.31%+103.30%+139.34%

Financials

2024 2025
Net sales 59.69B 42.35M 36.63M 34.21M 31.38M 59.02M 4.03B 59.96M 401M 158M 2.02B 159M 156M 6.68B 64.98B 46.1M 39.88M 37.24M 34.16M 64.26M 4.39B 65.28M 437M 171M 2.2B 173M 169M 7.27B
Net income 3.84B 2.72M 2.36M 2.2M 2.02M 3.8M 259M 3.86M 25.81M 10.13M 130M 10.23M 10M 429M 2.59B 1.83M 1.59M 1.48M 1.36M 2.56M 175M 2.6M 17.39M 6.82M 87.51M 6.89M 6.74M 289M
Net Debt -7.67B -5.44M -4.71M -4.4M -4.03M -7.59M -518M -7.71M -51.6M -20.25M -260M -20.44M -20M -859M -2.67B -1.9M -1.64M -1.53M -1.41M -2.64M -181M -2.69M -17.98M -7.06M -90.5M -7.12M -6.97M -299M
Logo C&R Research Inc.
C&R Research Inc is a Korea-based company is mainly engaged in the clinical trial agency and drug development business. The Company is mainly engaged in the provision of comprehensive early-stage clinical services in the areas of medical writing, regulatory matters, data management, biostatistics and others. The Company is mainly engaged in the provision of consulting services including initial clinical development, clinical trial development, global clinical trial development and others. In addition, the Company is also engaged in the operation of clinical trial training center.
Employees
510
Date Price Change Volume
07/08/26 1,896.00 +1.17% 9,543
06/08/26 ₩1,874.00 -0.64% 20,976
05/08/26 ₩1,886.00 +0.43% 14,951
04/08/26 ₩1,878.00 +3.76% 8,618
03/08/26 ₩1,810.00 +2.43% 9,757
  1. Stock Market
  2. Stocks
  3. A359090 Stock